Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 23, 2023

SELL
$203.72 - $248.97 $14,260 - $17,427
-70 Reduced 53.85%
60 $14,000
Q1 2022

May 04, 2022

SELL
$259.82 - $298.18 $54,562 - $62,617
-210 Reduced 61.76%
130 $34,000
Q4 2021

Feb 10, 2022

BUY
$271.6 - $314.21 $35,308 - $40,847
130 Added 61.9%
340 $107,000
Q3 2021

Nov 12, 2021

SELL
$274.82 - $308.34 $21,985 - $24,667
-80 Reduced 27.59%
210 $59,000
Q2 2021

Aug 11, 2021

BUY
$251.87 - $278.14 $73,042 - $80,660
290 New
290 $80,000

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.5B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Mitsubishi Ufj Morgan Stanley Securities Co., Ltd. Portfolio

Follow Mitsubishi Ufj Morgan Stanley Securities Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Morgan Stanley Securities Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mitsubishi Ufj Morgan Stanley Securities Co., Ltd. with notifications on news.